In the rapidly evolving landscape of medical writing, the integration of artificial intelligence (AI) is transforming how regulatory documents are produced. As the pharmaceutical industry seeks greater efficiency and accuracy, AI tools have emerged as powerful allies for medical writers. This blog summarizes insights from a recent discussion held at the Indegene Digital Summit, where industry experts shared their perspectives on the capabilities, limitations, and future of AI in medical writing. The panel featured prominent figures in the field, including Karen Rutkowski, Tatyana Wanderer and Julia Forjanic Klapproth.
